15-17 The first case report documenting the successful use of semaglutide in treating HS by Drumm et al 18 also showed a reduction in weight (24 kg), DLQI, narcotic analgesia use (from daily to not daily), and Hurley stage after six months of treatment
18% on placebo Growth concern / Long-term effects on linear growth, bone mineral density, and pubertal timing remain unstudied in pre-pubertal children Guideline position / The 2023 AAP Clinical Practice Guideline recommends pharmacotherapy starting at age 12, not younger Dose escalation schedule / The standard 16-week titration (0.25 mg to 2.4 mg weekly) has only been studied in patients aged 12 and above FDA Labeling: What Wegovy Is and Is Not Approved For in Children Wegovy received its initial FDA approval in June 2021 for adults with obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one weight-related comorbidity [1]
this is a federal statutory exclusion that applies to every Medicare plan, including all Humana Part D plans
Since the peptide promotes blood vessel formation, questions arise about whether it could support tumor growth in people with existing cancers
Electronic supplementary material Additional file 1: Supplementary Material Model Details for A Mathematical Model of Glutathione Metabolism
Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver